ENTITY
Takeda Pharmaceutical

Takeda Pharmaceutical (4502 JP)

292
Analysis
Health CareJapan
Takeda Pharmaceutical Co Ltd focuses on the Research & Development, Manufacturing, Sales and Marketing and Import/Export of Pharmaceutical Drugs. The Company focuses on the following core therapeutic areas: Cardiovascular & Metabolic, Oncology, Central Nervous System, Respiratory & Immunology, General Medicine (Gastrointestinal & Genitourinary) and Vaccine.
more
08 Nov 2018 16:30

Japan: Relative Price Score Update - Overbought and Oversold Sectors & Peer Groups

RELATIVE PRICE SCORE - The Relative Price Score (RPS) was introduced in an earlier insight and is a measure of stock price performance relative to...

Logo
577 Views
Share
06 Nov 2018 14:00

Smartkarma’s Week that Was in JP/​​KR: Softbank Telecom IPO & Shinsegae's Pursuit of Amazon Fresh

Below is the list of the Japan/Korea related posts put on the Smartkarma platform during the week of Oct 29.

Logo
559 Views
Share
04 Nov 2018 17:10

Japan Fortnightly Update: Lower Low as Earnings Slow

LOWER LOW - Japanese equities reached a new 52-week low on 29th October but rebounded on the subsequent four trading days to close the...

Logo
537 Views
Share
02 Nov 2018 14:50

Japan: The Evolution Of (Non-Financial) Market Leadership

28 YEARS OF NON-FINANCIAL MARKET LEADERSHIP - To offer some light relief from the current market, we have compiled a graphic illustrating the...

Logo
515 Views
Share
31 Oct 2018 20:06

Takeda 1H FY18 (YE Mar'19) Results - First Glance

Key highlights Notwithstanding brisk contribution by the key growth drivers including Entyvio (+33% to ~¥129b), Ninlaro (+36% to ~¥30b), Takecab...

x